The value of smuggled and counterfeit products seized at various entry points, including the Mombasa port, hit a record Sh243.5million in the year to December 2024, up from Sh200 million the previous ...
CARGO Therapeutic announced that it has elected to discontinue FIRCE-1, a Phase 2 clinical study of firi-cel for patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 ...
CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a competitive benefit-risk profile for patients.CARGO to ...
The delays in clearing of containers from port and customs created a multitude of issues which are interconnected — ships ...